IFIH1 and COVID-19: For this purpose, we have measured the activity of RIG-1/MDA-5 and JAK-STAT signaling pathways in whole blood of severe COVID-19 patients treated, or not, with VitD (50,000 IU cholecalciferol once per week for 2–3 weeks) during their hospital stay.